Literature DB >> 8903412

When is a carrier not a membrane carrier? The cytoplasmic transport of amphipathic molecules.

R A Weisiger1.   

Abstract

After entering the cell, small molecules must penetrate the cytoplasm before they are metabolized, excreted, or can convey information to the cell nucleus. Without efficient cytoplasmic transport, most such molecules would efflux back out of the cell before they could reach their targets. Cytoplasmic movement of amphipathic molecules (e.g., long-chain fatty acids, bilirubin, bile acids) is greatly slowed by their tendency to bind intracellular structures. Soluble cytoplasmic binding proteins reduce this binding by increasing the aqueous solubility of their ligands. These soluble carriers catalyze the transport of hydrophobic molecules across hydrophilic water layers, just as membrane carriers catalyze the transport of hydrophilic molecules across the hydrophobic membrane core. They even display the kinetic features of carrier-mediated transport, including saturation, mutual competition between similar molecules, and countertransport. Recent data suggest that amphipathic molecules cross the cytoplasm very slowly, with apparent diffusion constants 10(2) to 10(4) times smaller than in water. By modulating the rate of cytoplasmic transport, cytosolic binding proteins may regulate transport and metabolism of amphipathic molecules. Storage diseases may cause hepatocellular dysfunction by disrupting normal cytoplasmic transport.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8903412     DOI: 10.1002/hep.510240550

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

2.  Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells.

Authors:  F Schroeder; B P Atshaves; O Starodub; A L Boedeker; R R Smith; J B Roths; W B Foxworth; A B Kier
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

3.  In vitro binding of lidocaine to liver tissue under the influence of propranolol: another mechanism of interaction?

Authors:  C Tesseromatis; A Kotsiou; M Tsagataki; E Tigka; J Vovou; A Alevizou; C Perisanidis; T Saranteas; D Karakitsos; A Karabinis; G Kostopanagiotou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

Review 4.  Cytosolic fatty acid binding proteins catalyze two distinct steps in intracellular transport of their ligands.

Authors:  Richard A Weisiger
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

5.  Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver.

Authors:  M Weiss; O Kuhlmann; D Y Hung; M S Roberts
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Liver fatty acid binding protein expression enhances branched-chain fatty acid metabolism.

Authors:  Barbara P Atshaves; Stephen M Storey; Huan Huang; Friedhelm Schroeder
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

7.  Mechanisms of intracellular fatty acid transport: role of cytoplasmic-binding proteins.

Authors:  Richard A Weisiger
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

Review 8.  Mechanisms of endocannabinoid transport in the brain.

Authors:  Martin Kaczocha; Samir Haj-Dahmane
Journal:  Br J Pharmacol       Date:  2021-05-27       Impact factor: 9.473

9.  Validation of Recombinant Chicken Liver Bile Acid Binding Protein as a Tool for Cholic Acid Hosting.

Authors:  Giusy Tassone; Maurizio Orlandini; Massimo Olivucci; Cecilia Pozzi
Journal:  Biomolecules       Date:  2021-04-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.